• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov12
General Proximity Enters into Multi-target Collaboration with Daiichi Sankyo for Novel Oncology Drug Development
16:35
Nov10
Daiichi Sankyo Initiates First-In-Human Clinical Trial for DS3610
12:03
Oct31
Daiichi Sankyo released FY2026 Semi-Annual Earnings on October 31 During-Market (EST), Actual Revenue USD 6.65 B (Forecast USD 6.162 B), Actual EPS USD 0.4808
20:00
Daiichi Sankyo released FY2026 Q2 earnings on October 31 During-Market EST, actual revenue USD 3.369 B (forecast USD 3.306 B), actual EPS USD 0.1646
20:00
AstraZeneca's Breast Cancer Drug Enhertu Approved by Health Canada
08:46
Daiichi Sankyo and AstraZeneca Initiate DESTINY-Lung06 Phase 3 Clinical Trial for ENHERTU® and Pembrolizumab Combination Therapy in NSCLC
06:12

Schedules & Filings

Schedules
Filings
Oct31
Earning Release(EST)

FY2026 Q2 Earning Release (USD) Revenue 3.369 B, Net Income 304.88 M, EPS 0.1646

Sep30
Distribution Plan(EST)

Cash dividend 0.2698 USD

Distribution Plan(EST)

Cash dividend 0.2698 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
LPTX
2.050
+368.57%
+1.612
OPP.RT
0.0065
+140.74%
+0.004
CMCT
9.430
+88.22%
+4.420
SPRU
4.720
+54.75%
+1.670
FTCI
11.100
+49.19%
+3.660
QH
1.230
+48.14%
+0.400
MSGM
4.880
+45.67%
+1.530
DTSQR
0.2600
+44.44%
+0.080
MAGH
1.940
+41.61%
+0.570
ALPS
0.8200
+36.28%
+0.218
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy